Literature DB >> 29459485

p13 protects against Parkinson's disease.

Jorge S Valadas1,2, Patrik Verstreken1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29459485      PMCID： PMC5836093          DOI： 10.15252/embr.201845900

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  7 in total

Review 1.  Toxin models of mitochondrial dysfunction in Parkinson's disease.

Authors:  Terina N Martinez; J Timothy Greenamyre
Journal:  Antioxid Redox Signal       Date:  2011-07-12       Impact factor: 8.401

Review 2.  Therapeutic strategies in Parkinson's disease: what we have learned from animal models.

Authors:  Jorge S Valadas; Melissa Vos; Patrik Verstreken
Journal:  Ann N Y Acad Sci       Date:  2014-12-16       Impact factor: 5.691

3.  p13 overexpression in pancreatic β-cells ameliorates type 2 diabetes in high-fat-fed mice.

Authors:  Shintaro Higashi; Kazuhiko Katagi; Norihito Shintani; Kazuya Ikeda; Yukihiko Sugimoto; Soken Tsuchiya; Naoki Inoue; Shota Tanaka; Mai Koumoto; Atsushi Kasai; Takanobu Nakazawa; Atsuko Hayata-Takano; Ken-Ichi Hamagami; Shuhei Tomimoto; Takuya Yoshida; Tadayasu Ohkubo; Kazuki Nagayasu; Yukio Ago; Yusuke Onaka; Ryota Hashimoto; Atsushi Ichikawa; Akemichi Baba; Hitoshi Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  2015-04-23       Impact factor: 3.575

4.  PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.

Authors:  Derek P Narendra; Seok Min Jin; Atsushi Tanaka; Der-Fen Suen; Clement A Gautier; Jie Shen; Mark R Cookson; Richard J Youle
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

5.  Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function.

Authors:  Brendan J Floyd; Emily M Wilkerson; Mike T Veling; Catie E Minogue; Chuanwu Xia; Emily T Beebe; Russell L Wrobel; Holly Cho; Laura S Kremer; Charlotte L Alston; Katarzyna A Gromek; Brendan K Dolan; Arne Ulbrich; Jonathan A Stefely; Sarah L Bohl; Kelly M Werner; Adam Jochem; Michael S Westphall; Jarred W Rensvold; Robert W Taylor; Holger Prokisch; Jung-Ja P Kim; Joshua J Coon; David J Pagliarini
Journal:  Mol Cell       Date:  2016-08-04       Impact factor: 17.970

6.  Aconitase causes iron toxicity in Drosophila pink1 mutants.

Authors:  Giovanni Esposito; Melissa Vos; Sven Vilain; Jef Swerts; Jorge De Sousa Valadas; Stefanie Van Meensel; Onno Schaap; Patrik Verstreken
Journal:  PLoS Genet       Date:  2013-04-25       Impact factor: 5.917

7.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function.

Authors:  Vanessa A Morais; Patrik Verstreken; Anne Roethig; Joél Smet; An Snellinx; Mieke Vanbrabant; Dominik Haddad; Christian Frezza; Wim Mandemakers; Daniela Vogt-Weisenhorn; Rudy Van Coster; Wolfgang Wurst; Luca Scorrano; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2009-05       Impact factor: 12.137
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.